Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
27
users have liked this narrative
8
users have commented on this narrative
76
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
97
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
WuXi Biologics (Cayman)
AN
AnalystLowTarget
Consensus Narrative from 26 Analysts
Escalating Geopolitical And Regulatory Risks Will Disrupt CDMO Markets
Key Takeaways Geopolitical tensions and regulatory scrutiny threaten WuXi Biologics' access to key global markets, undermining revenue stability and growth prospects. Supply chain localization trends and intensified competition risk reducing facility utilization, increasing pricing pressure, and eroding both margins and earnings visibility.
View narrative
HK$20.94
FV
41.9% overvalued
intrinsic discount
14.76%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
SRF
AN
AnalystLowTarget
Consensus Narrative from 29 Analysts
Global Oversupply And Tough Regulations Will Weaken Margins
Key Takeaways Accelerated global shifts to green materials and stricter regulations threaten core chemical segments, increasing compliance costs and pressuring earnings and margins. Overreliance on fluorochemicals and ongoing heavy capital expenditure amplify risks from market volatility, oversupply, and disruptive innovation.
View narrative
₹2.21k
FV
30.4% overvalued
intrinsic discount
8.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Mitsubishi Chemical Group
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Regulatory Tightening And Overcapacity Will Limit Recovery
Key Takeaways Regulatory and market shifts are shrinking core chemical markets, increasing costs, and pressuring revenue and margins. Strategic pivots toward specialties face execution issues and competition, slowing recovery and weighing on profitability.
View narrative
JP¥700.00
FV
12.6% overvalued
intrinsic discount
-3.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Stora Enso Oyj
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
European Markets Will Suffer Under Digital, Regulatory And Climate Risks
Key Takeaways Reliance on European markets and legacy products exposes the company to declining demand and increased competition amid digitalization and demographic stagnation. Regulatory, ESG, and climate risks are raising costs and uncertainty, challenging the company's profitability and success of new capital investments.
View narrative
€8.20
FV
22.1% overvalued
intrinsic discount
2.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
SBI Cards and Payment Services
AN
AnalystLowTarget
Consensus Narrative from 25 Analysts
UPI Growth And Data Risks Will Erode Credit Returns
Key Takeaways Rapid growth of digital payments and fintech competitors threatens the long-term relevance and profitability of traditional credit card offerings. Rising regulatory, compliance, and credit risks are likely to constrain margins and increase earnings volatility amid shifting market dynamics.
View narrative
₹675.00
FV
18.2% overvalued
intrinsic discount
28.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Cathay Pacific Airways
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Geopolitical Tensions And Rising Costs Will Cripple Yields
Key Takeaways Geopolitical uncertainty, regulatory risks, and Hong Kong's volatility threaten future passenger and cargo revenue as travel and trade patterns shift. Rising costs from fleet delays, capacity expansion, and reduced pricing power may compress margins, limiting the company's long-term earnings growth.
View narrative
HK$8.20
FV
28.0% overvalued
intrinsic discount
2.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
NMDC
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
ESG Pressures And Decarbonization Will Erode Iron Ore Margins
Key Takeaways Global decarbonization trends and alternative materials threaten NMDC's growth by reducing steel and iron ore demand, while stricter ESG norms raise operational costs and investment risks. Delayed international expansion and shrinking high-grade reserves increase dependency on India, escalate production costs, and intensify competition's impact on profitability.
View narrative
₹55.00
FV
28.5% overvalued
intrinsic discount
3.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Indian Railway Catering & Tourism
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Improved Highways And Digital Platforms Will Erode Ticket Revenue
Key Takeaways Rising competition from air travel, highways, and digital platforms threatens IRCTC's core user base and market share, impacting revenue and convenience fee growth. Increased regulatory pressures and higher compliance costs are likely to compress margins and constrain profitability, even as modest sales increases persist.
View narrative
₹560.00
FV
29.2% overvalued
intrinsic discount
6.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Raia Drogasil
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Accelerating E-Commerce Shift And Rapid Expansion Will Compress Margins
Key Takeaways Rising digital adoption and intense new competition may erode margins, limit sales growth, and threaten Raia Drogasil's traditional competitive advantages. Accelerated store expansion risks market saturation, lower revenue per location, and growing costs, undermining long-term profitability.
View narrative
R$14.50
FV
21.7% overvalued
intrinsic discount
12.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies